MedTech Dive: J&J’s Impella heart pump shows no patient benefit in 2 trials Fierce Biotech: Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ benefits, spanning specific cases in patients with blockages in their coronary ... Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies Abiomed is recalling all Impella left-sided blood pumps in the US over a potential safety issue when used in patients with a transcatheter aortic valve replacement (TAVR) stent ― something that is not ... High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow ...
abc13: New warnings about heart pumps linked to more than 100 serious injuries, including 49 deaths There are new and revised warnings about the instructions for use of a certain type of heart pump that could lead to a risk of heart perforation, according to an alert issued by the pump's ...
